Dr Samuel Richard Williams, MD | |
5707 Calverton St, Suite 1b, Catonsville, MD 21228-4154 | |
(410) 788-2350 | |
(410) 788-6859 |
Full Name | Dr Samuel Richard Williams |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 5707 Calverton St, Catonsville, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568446599 | NPI | - | NPPES |
138181400 | Medicaid | MD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | D0024752 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Samuel Richard Williams, MD 5707 Calverton St, Suite 1b, Catonsville, MD 21228-4154 Ph: (410) 788-2350 | Dr Samuel Richard Williams, MD 5707 Calverton St, Suite 1b, Catonsville, MD 21228-4154 Ph: (410) 788-2350 |
News Archive
Pico-Tesla, The Magneceutical® Company, announced that it has commenced a randomized, double-blind, placebo-controlled pilot study of 30 patients who have fibromyalgia. The pilot study seeks to determine whether the application of magnetic fields generated by Pico-Tesla's patented Resonator™ system can be effective as an adjunctive therapy to oral medications in ameliorating the symptoms of fibromyalgia.
Obstructive sleep apnea (OSA) is a chronic condition in which enhancement of patient self-efficacy is critical for long-term management.
Resverlogix Corp. ("Resverlogix" or the "Company") announced today that it has begun dosing patients in its US Phase 2 clinical trial lead by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with stable coronary artery disease (CAD).
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it will launch the APP Drug Hotline on Wednesday, November 10, 2010. The APP Drug Hotline has been established to assist healthcare professionals with critical drug shortage issues.
ProStrakan, Inc., a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that the U.S. Food and Drug Administration has approved the TIRF (Transmucosal Immediate Release Fentanyl) REMS Access program.
› Verified 8 days ago
Joshua Sol Madden, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1011 Frederick Rd, Catonsville, MD 21228 Phone: 410-744-4849 Fax: 410-744-9668 | |
Mohammad Iqbal, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2 W Rolling Crossroads, Suite 112, Catonsville, MD 21228 Phone: 410-988-2912 | |
Dr. John H Moye Jr., M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1810 Frederick Rd, Catonsville, MD 21228 Phone: 301-496-7339 Fax: 301-496-8678 | |
Dr. Henry Hou J Chang, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Geipe Rd Ste 210, Catonsville, MD 21228 Phone: 443-451-1600 Fax: 443-451-1619 | |
Dr. Sherri L Gruneberg, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 405 Frederick Rd, Suite 210, Catonsville, MD 21228 Phone: 410-788-6565 Fax: 410-747-4688 | |
Dr. Leena D Parikh, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 516 N Rolling Rd, Catonsville, MD 21228 Phone: 410-788-1540 Fax: 410-788-1577 | |
Dr. Jovonsia M Taylor, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4 W Rolling Xrds Ste 100, Catonsville, MD 21228 Phone: 410-869-0100 Fax: 410-601-7317 |